• 4009 Hackney Springs Ln, Sachse, TX 75048
Inquire Now
Genetics & Genomics Billing Services

Genetics & Genomics Billing Services That Capture Every Test You Run

Genetic testing billing runs through a coding system that changes yearly, where near-identical tests can bill as different claims. A cancer panel can bill correctly under one PLA code, incorrectly as separate gene codes, or be denied for a missing MolDX Z-Code. Payers deny about one in five prior authorizations, often calling appropriate testing “not medically necessary” or “experimental.” TransLabs’ certified coders deliver 98% clean claims, 28% faster A/R with 90-day recovery.
Get In Touch
Genetics & Genomics Billing Services
0%
Client Retention Rate
0%
First-Pass Claim Rate
0%
Avg. Revenue Growth
0%
Avg. Denial Reduction

Why Genetics & Genomics Labs Lose Revenue Every Single Day

Genetic testing runs through more coding pathways than almost any other lab specialty: Tier 1 analyte-specific codes, Tier 2 effort-based codes, Genomic Sequencing Procedure codes, PLA codes, and an unlisted code as a catch-all. Each has its own hierarchy rule. Bill the wrong one and, increasingly, the claim doesn’t get paid less; it doesn’t get paid, because the expected MolDX Z-Code or PLA code never made it onto the line.

The Five Revenue Leaks Most Genetics & Genomics Labs Don’t Know They Have

PLA-Over-Tier Code Hierarchy Violations

Missing MolDX Z-Code / DEX Registration

Genomic Sequencing Panel Component Stacking

Prior Authorization and Genetic Counseling Documentation Gaps

Multianalyte Assay (MAAA) Component Unbundling

Genetics & Genomics Billing Services

Genetics & Genomics Testing, Every Category, Coded to the Correct Hierarchy

From single-gene hereditary testing to whole exome sequencing and combinatorial pharmacogenomic panels, our AAPC and AHIMA certified coders know the code hierarchy, the Z-Code registration requirements, and the payer-specific documentation rules for every category of genetic and genomic testing.

Germline Single-Gene & Tier 1 Molecular Pathology Testing

CPT 81161–81355

Analyte-specific hereditary gene testing including BRCA1/BRCA2 full sequence and duplication/deletion analysis (81162–81167), known familial variant testing (81212), CFTR analysis, Factor V Leiden, and MTHFR.

Key Billing Consideration

Tier 1 codes are gene-specific, and the correct code depends on exactly what the order requests; full sequence analysis, known familial mutation testing, or duplication/deletion analysis carry different codes, and billing full sequencing when the order only supports known-variant testing is a recurring overpayment and audit trigger.

Tier 2 Molecular Pathology & Low-Volume Gene Analysis

CPT 81400–81408

Rare hereditary condition testing for genes without a dedicated analyte-specific code, organized into nine effort-based levels rather than named by gene.

Key Billing Consideration

Because Tier 2 descriptors don’t name the gene being tested, payers require supplemental documentation identifying the test name, the specific gene or genes, the method, and the clinical rationale; claims missing that documentation are pended or denied at a materially higher rate than gene-named Tier 1 claims.

Multigene Panels & Genomic Sequencing Procedures (GSP)

CPT 81410–81471, 81479

Hereditary cancer panels, cardiac arrhythmia and cardiomyopathy panels, hereditary hearing loss panels, epilepsy panels, and clinical exome or genome sequencing.

Key Billing Consideration

When a defined GSP panel code exists, it must be reported instead of stacking individual Tier 1 or Tier 2 codes for the same genes; reporting multiple codes for overlapping genes is treated as incorrect coding and denied. The unlisted code 81479 is reserved for tests with no defined code anywhere in the set and carries a heavier documentation burden and closer payer scrutiny.

Proprietary Laboratory Analyses (PLA)

MolDX Z-Code Testing

Proprietary branded panels such as hereditary cancer next-generation sequencing panels and tumor genomic profiling assays, each assigned an alphanumeric PLA code ending in “U.”

Key Billing Consideration

A valid PLA code takes precedence over Tier 1 or Tier 2 codes and must be reported whenever one exists for the test performed. A growing number of MACs and commercial payers additionally require a MolDX DEX Z-Code, registered to that specific test, alongside the CPT or PLA code; without it, the claim is denied regardless of medical necessity.

Pharmacogenomic (PGx) Testing

CPT 81225–81227, 81328, 81479

CYP2D6, CYP2C19, CYP2C9, and VKORC1 single-gene testing, plus combinatorial PGx panels used to guide psychiatric, cardiac, and pain management medication selection.

Key Billing Consideration

Payers increasingly limit reimbursable PGx testing to genes tied to a specific prescribed or contemplated medication, and combinatorial multi-gene panels billed without a documented medication-management indication; particularly for psychiatric prescribing, are one of the fastest-growing genetic testing denial categories.

Non-Invasive Prenatal & Reproductive Genetic Testing

CPT 81420–81422, 81507

Cell-free fetal DNA aneuploidy screening, expanded carrier screening panels, and first-trimester combined screening biomarkers.

Key Billing Consideration

Many commercial plans still require prior authorization and documented patient counseling for NIPT, despite professional society guidance that the screening be offered to all pregnant patients regardless of risk category, and claims lacking that counseling attestation are a leading source of denial.

Oncology Genomic Profiling & Liquid Biopsy Testing

CPT 81445–81455, 81500–81599

Solid tumor next-generation sequencing panels, germline-versus-somatic variant distinction, circulating tumor DNA (liquid biopsy) testing, and algorithmic multianalyte assays such as recurrence-risk scores.

Key Billing Consideration

Multianalyte Assay with Algorithmic Analysis (MAAA) results are reported under one specific code covering the algorithmic score itself — billing the individual component analytes that feed that algorithm as additional separate codes is explicitly prohibited and denied as unbundling.

Our Laboratory RCM Services

TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.

Lab Rcm services

Revenue Cycle
Management

End-to-end financial management covering patient registration, claims submission, payment posting, and final collection. Our integrated approach optimizes every revenue touchpoint to maximize reimbursements and eliminate costly gaps in your billing workflow.
Billing and coding

Billing & Coding
Services

AAPC/AHIMA certified coders ensure precise CPT, ICD-10, and HCPCS code assignment across all laboratory specialties. Accurate coding reduces denials, accelerates payments, and keeps your lab fully compliant with evolving payer requirements
lab credentialing

Credentialing
Services

Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.

Eligibility Verification

Eligibility
Verification services

Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.

RCM Automation services

RCM
Automation services

Intelligent RCM automation reduces manual tasks by 80%, accelerates claims processing 3x faster, and eliminates costly billing errors. Our automation solutions free your staff from repetitive workflows so they can focus on higher-value patient care activities.

Front Office
Management

Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.

Lab Billing audit

Complimentary
Revenue Audit

Complimentary 12-month analysis identifying revenue leakage, denial patterns, and untapped improvement opportunities potentially worth thousands in recovered revenue. No obligation, no risk—just a clear picture of what your lab is leaving on the table.
AR Management

AR
Management

Systematic accounts receivable follow-up, aging management, and payment acceleration strategies designed to reduce AR days by 30%. We pursue every outstanding balance with disciplined follow-up so no earned revenue is left uncollected.
Denial Management

Denial
Management

Expert appeal preparation achieving an 85% success rate backed by comprehensive root cause analysis and targeted prevention strategies. We fight every denial aggressively while addressing underlying issues to stop recurring revenue losses.
View All

Proficient Across Multiple LIS & EHRs to Simplify Your
 Laboratory Management

ChartLogic
Collaborate md
Greenway health
Haemonetics
jane
cgm Labdaq
Modmed
open emr
Harris Data Integrity Solutions
siemens healthineers
Tebra
Oracle Health
Confience
Power path
Benchmark solutions
Xifin
Psyche Systems
veradigm
Turemed Lis
Telcor
Practice pro
novo path
Nextgen Healthcare
Next tech
meditech
Advanced data systems corporation
Logilab
Labware
Lab vantage
labs os
Epic
Dr Chrono
dendi
Corepoint
clinisys
Care Cloud
apex healthware
clinisys copathplus
Advanced md
softlab
athenaone

Serving Labs Across The United States

TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.

View Your State

Medicare Part B Compliance for Genetics & Genomics Testing

Genetics and genomics testing under Medicare Part B carries code hierarchy rules, MolDX Z-Code registration requirements, and panel bundling logic that catch generalist billing companies off guard on a routine basis. The combination of Local Coverage Determinations, MolDX technical assessments, CLIA certification tiers, and frequency limitations requires dedicated, proactive management.
Get in Touch
Local Coverage Determinations (LCDs)

Each Medicare Administrative Contractor maintains its own LCD specifying which ICD-10 codes support coverage for hereditary panels, pharmacogenomic testing, and tumor genomic profiling. TransLabs maintains live LCD databases for every MAC and validates diagnosis code linkage on every genetics and genomics claim before submission.

PLA-Over-Tier Coding Hierarchy Edits

A valid Proprietary Laboratory Analyses code must be reported instead of a Tier 1 or Tier 2 molecular pathology code whenever one exists for the test performed, and reporting both is treated as incorrect coding. TransLabs runs every claim through a hierarchy check before it leaves our system, not after a denial arrives.

MolDX Z-Code / DEX Registration

Molecular and genetic tests billed within a MolDX jurisdiction, and increasingly within commercial Medicare Advantage plans, require a registered DEX Z-Code alongside the CPT or PLA code. TransLabs verifies Z-Code registration status for every test your lab offers and manages the technical assessment process for tests not yet registered.

CLIA Certification Tiers

Genetic and genomic testing is classified as moderate- or high-complexity testing under CLIA, requiring the corresponding certificate before any claim can be submitted. TransLabs verifies that the CPT, GSP, or PLA code billed matches the CLIA certification level the lab actually holds.

Advance Beneficiary Notices (ABNs)

Traditional Medicare does not offer prior authorization for most genetic testing, which means a beneficiary requesting testing that may not meet an LCD's medical necessity criteria needs a valid ABN issued before the specimen is collected. TransLabs builds ABN workflows into front-end registration so the documentation is always in place.

Clinical Laboratory Fee Schedule (CLFS)

The CLFS sets Medicare payment rates for Tier 1, Tier 2, GSP, and many PLA-coded genetic tests, and updates annually on January 1. TransLabs monitors CLFS changes, updates billing tables immediately, and flags payers reimbursing below CLFS rates.

We Bill Genetics & Genomics Exclusively, and the Accuracy Shows

Genetics and genomics testing has its own code hierarchy framework, its own MolDX Z-Code registration process, its own panel bundling logic, and its own CLIA certification structure. TransLabs was built for laboratory billing specifically, and every coder assigned to a genetics or genomics account works in that testing category day in and day out.

Genetics & Genomics-Exclusive Coding Teams

Your coders specialize in genetic and genomic testing, PLA hierarchy, GSP bundling, MAAA reporting; not every lab discipline at once.

98% First-Pass Clean Claims Rate

98%+ clean claims rate across all lab clients with fewer denials, faster payments, stronger cash flow.

Code-Hierarchy Validation Engine

Automated logic flags Tier 1/Tier 2 codes when a PLA code should apply, and catches missing MolDX Z-Codes; both drivers of genetic testing denials.

MolDX & Prior Authorization Expertise

We get DEX Z-Codes, technical assessments, and prior auth right from day one with counseling attestations for hereditary and prenatal panels included.

No Long-Term Contracts

Month-to-month, results-based partnership with measurable improvement in 90 days, no exit fees, just 30 days’ notice.

Transparent Reporting

Monthly dashboards with full visibility of clean claims rate, denial trends, A/R aging, and root cause analysis, no surprises.
Improve My Revenue

Get Your Genetics & Genomics Custom Revenue Recovery Plan

Schedule a call with our genetics and genomics billing specialist. We’ll review your code hierarchy, Z-Code registration status, panel bundling, and A/R days.
Improve My Revenue

What Our Clients Say?

Linda Hutchinson
Linda Hutchinson
★★★★★
Laboratory Director
Our NGS panel denials dropped from 32% to under 6% within three months. TransLabs' expertise with molecular tier codes, prior authorization management, and LCD compliance has been invaluable. They understand the nuances of genetic testing billing that our previous vendor completely missed.
Peter Wozniak
Peter Wozniak
★★★★★
Pathologist & Laboratory Owner
We've worked with three other billing companies over the years. TransLabs is the only one that truly understands complex surgical pathology coding, immunohistochemistry billing, and the nuances of TC/PC modifiers. Clean claims rate improved to 99%, and our dermatopathology reimbursement increased 27%.
James Patton
James Patton
★★★★★
Cytogenetics Laboratory Manager
Before TransLabs, our FISH and karyotype claims were a constant struggle with denials and underpayments. Their coders actually understand probe configurations, complexity levels, and when to use 88271 versus 88275. Our cytogenetics revenue increased 34% in the first year.

Book Consultation Today!

Stop Leaving Genetics & Genomics Reimbursements on the Table

Join 250+ genetics clinics, molecular diagnostic laboratories, and specialty practices that trust TransLabs, the laboratory billing company built for growth. Start with our complimentary claims audit. Our genetics and genomics billing specialists will review your CPT/PLA coding, Z-Code registration status, and denial trends to show you exactly what’s recoverable.

Dedicated genetics & genomics billing specialist assigned to your practice

Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers

Uncover your top 3 revenue leaks in code hierarchy, Z-Code registration, and panel bundling

Custom strategy tailored to your testing platform and LIS/billing software

Live in 24 hours with no contracts and no upfront fees

Frequently Asked Questions

What’s the difference between Tier 1, Tier 2, and PLA codes?

Tier 1 codes are gene-specific analyte codes (like BRCA1/BRCA2), Tier 2 codes cover less common genes organized by technical effort level rather than gene name, and PLA codes are proprietary alphanumeric codes assigned to specific branded tests. When a valid PLA code exists for a test, it must be reported instead of a Tier 1 or Tier 2 code — billing both, or billing the wrong tier, is treated as incorrect coding.
A DEX Z-Code is a unique identifier assigned by the MolDX program to a specific molecular or genetic test, distinguishing it from similar assays offered by other labs. A growing number of Medicare Administrative Contractors and commercial payers, including UnitedHealthcare and Humana, deny the associated CPT or PLA code outright if it isn’t reported alongside the test’s registered Z-Code.
No. When a defined Genomic Sequencing Procedure (GSP) panel code already covers the genes tested, billing those same genes separately under Tier 1 or Tier 2 codes is treated as reporting multiple codes for the same analyte and results in denial of the duplicate lines.
In most cases, yes, for commercial and Medicare Advantage plans. Traditional Medicare doesn’t offer prior authorization for most genetic testing, which is why an Advance Beneficiary Notice matters when medical necessity under the applicable LCD is uncertain. Published research on genetic testing authorizations found close to one in five requests denied, most often for medical necessity or experimental-use determinations.
Genetic and genomic testing is classified as moderate- or high-complexity testing under CLIA. A Certificate of Waiver is not sufficient — the lab needs the appropriate moderate- or high-complexity certification matched to the specific testing methodology performed.
MAAA tests report a single algorithmic result, such as a recurrence-risk score, under one designated code. Billing the individual component analyses that feed that algorithm as additional line items is explicitly prohibited and denied as unbundling, even though each component result technically exists.
Yes. Non-invasive prenatal testing and expanded carrier screening carry payer-specific prior authorization and counseling-documentation requirements that vary significantly by plan, and we validate that documentation before claims go out to avoid the counseling-attestation denials that are common in this category.
Most genetics and genomics labs see measurable improvement within 60–90 days: code-hierarchy corrections and Z-Code registration checks are live within the first 30 days, denial rate improvement follows by day 60, and by day 90 clients typically see a 95%+ clean claims rate with documented revenue recovery from previously miscoded and unbundled claims.

Your Trusted Lab Billing Partner

Book Your Free Consultation

Book Consultation Today!

Book Consultation Today!